Discontinuation of first-line disease-modifying therapy in relapse onset multiple sclerosis

Discontinuation of Disease-Modifying Therapy in Multiple Sclerosis

(2021) Eva M. M. Strijbis et al.   JAMA Neurology

Association of Age With Contrast-Enhancing Lesions Across the Multiple Sclerosis Disease Spectrum

(2021) Marcus W. Koch et al.   NEUROLOGY

Gadolinium enhancement on cranial MRI in multiple sclerosis is age dependent

(2020) Marcus W. Koch et al.   JOURNAL OF NEUROLOGY

Quantifying the risk of disease reactivation after interferon and glatiramer acetate discontinuation in multiple sclerosis: The VIAADISC score

(2020) Gabriel Bsteh et al.   EUROPEAN JOURNAL OF NEUROLOGY

Age-related decreases in relapses among adults with relapsing-onset multiple sclerosis

(2019) Natalie A Schwehr et al.   Multiple Sclerosis Journal

Discontinuation of disease-modifying therapy for patients with relapsing-remitting multiple sclerosis: Effect on clinical and MRI outcomes

(2019) Hajime Yano et al.   Multiple Sclerosis and Related Disorders

Disease-modifying treatments for early and advanced multiple sclerosis

(2018) Gavin Giovannoni   CURRENT OPINION IN NEUROLOGY

ECTRIMS/EAN guideline on the pharmacological treatment of people with multiple sclerosis

(2018) X. Montalban et al.   EUROPEAN JOURNAL OF NEUROLOGY

Predictors of relapse and disability progression in MS patients who discontinue disease-modifying therapy

(2018) Ilya Kister et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Multiple Sclerosis

(2018) Daniel S. Reich et al.   NEW ENGLAND JOURNAL OF MEDICINE

Can we stop immunomodulatory treatments in secondary progressive multiple sclerosis?

(2016) J. Bonenfant et al.   EUROPEAN JOURNAL OF NEUROLOGY

Discontinuing disease-modifying therapy in MS after a prolonged relapse-free period: a propensity score-matched study

(2016) Ilya Kister et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Discontinuation of disease-modifying therapies in multiple sclerosis – Clinical outcome and prognostic factors

(2016) Gabriel Bsteh et al.   Multiple Sclerosis Journal

Discontinuation of disease-modifying therapies in multiple sclerosis – Clinical outcome and prognostic factors

(2016) Gabriel Bsteh et al.   Multiple Sclerosis Journal

Relapses in multiple sclerosis are age- and time-dependent

(2008) H Tremlett et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY